切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (03) : 193 -195. doi: 10.3877/cma.j.issn.1674-0807.2022.03.012

病例报告

淋巴细胞性乳腺炎一例并文献复习
孙珂1, 李嗣杰1, 陈奕蒙1, 毕丽荣1, 范志民1,()   
  1. 1. 130012 长春,吉林大学白求恩第一医院乳腺外科
  • 收稿日期:2019-11-06 出版日期:2022-06-01
  • 通信作者: 范志民

Lymphocytic mastitis: one case report and literature review

Ke Sun1, Sijie Li1, Yimeng Chen1   

  • Received:2019-11-06 Published:2022-06-01
引用本文:

孙珂, 李嗣杰, 陈奕蒙, 毕丽荣, 范志民. 淋巴细胞性乳腺炎一例并文献复习[J/OL]. 中华乳腺病杂志(电子版), 2022, 16(03): 193-195.

Ke Sun, Sijie Li, Yimeng Chen. Lymphocytic mastitis: one case report and literature review[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2022, 16(03): 193-195.

淋巴细胞性乳腺炎(lymphocytic mastitis,LM),是一种非常罕见的良性乳腺疾病,又称硬化性淋巴细胞性小叶炎或糖尿病性乳腺病,仅占良性乳腺病变的1%,在1型糖尿病患者中更常见(占13%)[1]。其发病机制不明,可能与自身免疫有关,临床表现与乳腺癌类似,确诊主要依靠组织病理学,文献报道局部切除后容易复发[2]。吉林大学白求恩第一医院收治了1例LM患者,现报道如下。

图1 淋巴细胞性乳腺炎标本的免疫组织化学染色 a图所示CD20阳性B淋巴细胞围绕小叶腺体周边弥漫浸润(EnVision ×200);b图所示CD3阳性T淋巴细胞围绕小叶腺体周边弥漫浸润(EnVision ×200);c图所示CK7阳性的乳腺小叶及小导管腺体减少、萎缩(EnVision ×100);d图所示增生的淋巴组织形成淋巴滤泡(箭头所指处),Bcl-2呈阴性表达(EnVision ×200) 注:CD为白细胞分化抗原;CK为细胞角蛋白
图2 淋巴细胞性乳腺炎的病理表现(HE ×40) 注:乳腺小叶萎缩,小叶、导管及血管周边见大量淋巴细胞及少量浆细胞浸润
[1]
Hunfeld KP, Bassler R.Lymphocytic mastitis and fibrosis of the breast in long-standing insulin-dependent diabetics. A histopathologic study on diabetic mastopathy and report of ten cases[J].Gen Diagn Pathol1997, 143 (1): 49-58.
[2]
Ricart Selma V, Camps Herrero J, Martinez Rubio C, et al. Diabetic mastopathy: clinical presentation, imaging and histologic findings, and treatment[J].Radiologia2011, 53 (4): 349-354.
[3]
Soler NG, Khardori R.Fibrous disease of the breast, thyroiditis, and cheiroarthropathy in type I diabetes mellitus[J].Lancet1984, 1(8370): 193-195.
[4]
Byrd BF Jr, Hartmann WH, Graham LS, et al.Mastopathy in insulin-dependent diabetics[J].Ann Surg1987, 205 (5): 529-532.
[5]
Tomaszewski JE, Brooks JS, Hicks D, et al.Diabetic mastopathy: a distinctive clinicopathologic entity[J].Hum Pathol1992, 23(7): 780-786.
[6]
Neetu G, Pathmanathan R, Weng NK.Diabetic mastopathy: a case report and literature review[J].Case Rep Oncol2010, 3 (2): 245-251.
[7]
Sanguedolce F, Ingravallo G, Marzullo A, et al.Lymphocytic mastitis without associated diabetes mellitus: a clinicopathological study of one male case[J].Histopathology2007, 50 (3): 391-393.
[8]
Rios G, Peredo RA.Lymphocytic mastitis preceding Sjogren's syndrome[J].P R Health Sci J2010, 29 (2): 127-129.
[9]
Agochukwu NB, Wong L.Diabetic mastopathy: a systematic review of surgical management of a rare breast disease[J].Ann Plast Surg2017, 78 (4): 471-475.
[10]
Cheng L, Reddy V, Solmos G, et al.Mastitis, a radiographic, clinical, and histopathologic review[J].Breast J2015, 21 (4): 403-409.
[11]
Lammie GA, Bobrow LG, Staunton MD, et al.Sclerosing lymphocytic lobulitis of the breast--evidence for an autoimmune pathogenesis[J].Histopathology1991, 19 (1): 13-20.
[12]
Park SH, Choi SJ, Jung HK. Sclerosing lymphocytic lobulitis manifesting as suspicious microcalcifications with Hashimoto’s thyroiditis in a young woman[J].Breast J2013, 19 (5): 539-541.
[13]
Miura K, Teruya C, Hatsuko N, et al.Autoantibody with cross-reactivity between insulin and ductal dells may cause diabetic mastopathy: a case study[J].Case Rep Med2012, 2012: 569 040.
[14]
Oba M, Sasaki M, Ii T, et al.A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma[J].Breast Cancer2009, 16 (2): 141-146.
[15]
Suvannarerg V, Claimon T, Sitthinamsuwan P, et al. Clinical, mammographic, and ultrasonographic characteristics of diabetic mastopathy: A case series[J].Clin Imaging2019, 53: 204-209.
[16]
Wong KT, Tse GM, Yang WT. Ultrasound and MR imaging of diabetic mastopathy[J].Clin Radiol2002, 57 (8): 730-735.
[17]
Tuncbilek N, Karakas HM, Okten O. Diabetic fibrous mastopathy: dynamic contrast-enhanced magnetic resonance imaging findings[J].Breast J2004, 10 (4): 359-362.
[18]
Thorncroft K, Forsyth L, Desmond S, et al. The diagnosis and management of diabetic mastopathy[J].Breast J2007, 13 (6): 607-613.
[19]
Ely KA, Tse G, Simpson JF, et al.Diabetic mastopathy. A clinicopathologic review[J].Am J Clin Pathol2000, 113 (4): 541-545.
[20]
Kudva YC, Reynolds C, O'brien T, et al. "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes[J].Diabetes Care2002, 25 (1): 121-126.
[21]
Valdez R, Thorson J, Finn WG, et al.Lymphocytic mastitis and diabetic mastopathy: a molecular, immunophenotypic, and clinicopathologic evaluation of 11 cases[J].Mod Pathol2003, 16(3): 223-228.
[22]
Aozasa K, Ohsawa M, Saeki K, et al.Malignant lymphoma of the breast. Immunologic type and association with lymphocytic mastopathy[J].Am J Clin Pathol1992, 97 (5): 699-704.
[23]
Menard S, Tomasic G, Casalini P, et al.Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas[J].Clin Cancer Res1997, 3 (5): 817-819.
[24]
Jose JM, Varghese A, Joseph G, et al.Infiltrating ductal carcinoma of the breast with coexisting lymphocytic mastitis in a non-diabetic adult female[J].BJR Case Rep2016, 2 (2): 20 150 234.
[25]
Yilmaz R, Yesil S, Bayramoglu Z, et al.Lymphocytic Mastopathy: Mimicker of Breast Malignancy[J].Breast J2017, 23 (2): 229-231.
[26]
Douglas-Jones AG. Lymphocytic lobulitis in breast core biopsy: a peritumoral phenomenon[J].Histopathology2006, 48 (2): 209-212.
[27]
Naidoo P, Chetty R. Lymphoepithelioma-like carcinoma of the breast with associated sclerosing lymphocytic lobulitis[J].Arch Pathol Lab Med2001, 125 (5): 669-672.
[28]
Decraene J, Van Ongeval C, Clinckemaillie G, et al.Sclerosing lymphocytic lobulitis mimicking a tumor relapse in a young woman with a history of breast cancer[J].J Belg Soc Radiol2015, 99 (1): 72-75.
[1] 杨桂清, 孟静静. 哺乳期亚临床乳腺炎的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 376-379.
[2] 王培蕾, 夏罕生, 俞清, 闻捷先, 黄备建. IgG4相关性乳腺炎多模态影像学表现及其治疗转归一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 244-247.
[3] 刘涵, 刘晓菲, 陈翰翰, 陈延君, 张雁. 妊娠期肉芽肿性乳腺炎一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 253-254.
[4] 丁丁, 杨云川, 马翔, 马中正, 霍俊一, 周磊. 术前C-反应蛋白-白蛋白-淋巴细胞比值在肝细胞癌预后中的价值评估[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 261-265.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 董学峰, 常乐, 蔡振煜. 血清ESR、CRP及PLR、MLR联合诊断结缔组织相关性间质性肺炎的意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 430-433.
[7] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[8] 伍细蓉, 徐立文, 陈亚琼. 基于LPR和FARI构建肝衰竭患者生存预后模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 675-681.
[9] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[10] 施麟宵, 洪兰兰, 阳柳, 芶碧珍, 刘畅, 吴欣. 钠-葡萄糖协同转运蛋白2 抑制剂治疗原发性膜性肾病的疗效及其对Th1/Th2 的影响[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 261-267.
[11] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[12] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[13] 崔秋子, 姚红曼, 艾迎春. 监测NLR、PLR、CAR、白蛋白、血钙及血糖指标水平对急性胰腺炎患者急性肾损伤的预测价值分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 244-248.
[14] 江小珍, 陈秀贤, 陈宗威. 培门冬酶化疗后发生极重度高三酰甘油的分析和治疗[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(03): 184-186.
[15] 席静妮, 李娜, 张琪. 中性粒细胞与淋巴细胞比值对老年重症社区获得性肺炎进展为脓毒症的预测价值[J/OL]. 中华老年病研究电子杂志, 2024, 11(03): 28-31.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?